Stock AnalizRH RH
Other Specialty Stores · IPO 2012 · data as of November 13, 2026
RH (RH) is a consumer discretionary company listed in the US with a market value of about $2.4B. In the twelve months to August 1, 2026 it had revenue of $3.4B and net income of $112M, a net margin of 3.2%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is value (3/5); the weakest is future growth (1/5).
Key numbers: a P/E of 23.0, a price to free cash flow of 9.8, 5-year revenue growth of 4% a year, a 5-year average ROIC of 13%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 51% above the current price.
Score: 2.0 / 5
Checks passed
- P/E below 25
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Profit margin improving
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- ROE above 15%
- Positive free cash flow
Checks not passed
- P/E below the industry median
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.4B | $3.2B | $3.0B | $3.6B | $3.8B | $2.8B | $2.6B | $2.5B | $2.4B | $2.1B |
| Net income | $112M | $125M | $72M | $128M | $529M | $689M | $272M | $220M | $136M | -$3M | $5M |
| Free cash flow | $251M | $252M | -$214M | -$67M | $230M | $477M | $390M | $246M | $170M | $406M | -$90M |
| EPS (diluted) | $5.63 | $6.31 | $3.62 | $5.91 | $19.90 | $22.13 | $9.96 | $9.07 | $5.12 | $-0.10 | $0.13 |
| Net margin | 3.2% | 3.6% | 2.3% | 4.2% | 14.7% | 18.3% | 9.5% | 8.3% | 5.4% | -0.1% | 0.2% |
| ROIC | — | 8.5% | 9.7% | 10.8% | 15.0% | 20.6% | 33.6% | 39.3% | 42.2% | 34.0% | 3.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 17 analysts is $164.41, 27% above the current price; targets range from $81.00 to $258.00; the consensus rating is “none”; expected EPS is $5.30 for the fiscal year ending January 31, 2027.
Frequently asked questions
What is RH’s P/E ratio?
About 23.0, based on the last twelve months of diluted earnings per share (forward P/E about 15.0).
Is RH stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 51% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does RH pay a dividend?
Not currently.
Is RH a good stock to buy?
We do not give buy or sell advice. RH scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.